HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

OPTH

Optimi Health Corp.

Healthcare — Drug Manufacturers - Specialty & Generic

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

None
$4.60
$-0.11 (-2.32%)

Price History

52-Week Range
Sign in to add OPTH to a watchlist or set price alerts.

Fundamentals

Market Cap$28.13M
P/E Ratio (TTM)-
Forward P/E-
EPS (TTM)$-1.21
Dividend Yield-
Profit Margin-
Revenue Growth62.50%
ROE-88.70%
Debt/Equity185.66
Recommendation None
Analyst Target-
Analysts-
Next Earnings -
Indexes -

Technical Indicators

RSI (14)53.3
Beta1.60
SMA 20-
SMA 40-
52-Week High$6.40
52-Week Low$4.00
50-Day Avg$4.99
200-Day Avg$4.99
Avg Volume265.5K
Volume272.5K

Performance Analysis

NEUTRAL

OPTH presents a mixed picture with both positive and negative indicators.

~ Trading at 25% of its 52-week range.
~ RSI at 53.3 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ Strong revenue growth of 62.5% year-over-year.
~ Wall Street consensus is "none".

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:24 UTC

Back to Screener Export Report